Navigation Links
NantOmics Acquires Genos To Bolster Its Precision Medicine Platform
Date:4/13/2017

CULVER CITY, Calif., April 13, 2017 /PRNewswire/ -- NantOmics, the leader in molecular diagnostics and a member of the NantWorks ecosystem of families, announced today the acquisition of Genos, the leading community for next-generation sequencing, personal genetic discovery and research, based in San Francisco.

Genos was spun out of Complete Genomics in 2016 and quickly has become the leader in making next-generation sequencing more accessible and giving individuals access to 50 times more data than current popular sequencing options as well as opportunities to participate in groundbreaking research projects.

NantOmics plans to integrate the Genos technology, technical expertise and data visualization and research platform into its pan-omic analysis tools, further bolstering the company's industry leading precision medicine service that integrates whole genomic sequencing, transcriptomics, predictive proteomics and quantitative proteomics.

"We are excited to integrate the Genos technology and to welcome Genos employees to the NantOmics team," stated Patrick Soon-Shiong, M.D., founder and CEO of NantOmics. "With the addition of the state-of-the-art discovery and research tools from Genos, NantOmics will enhance its comprehensive diagnostic platform which delivers patient-specific pan-omic information and, ultimately, improves disease diagnosis and treatment."

"NantOmics is a leader in enabling precision medicine and Genos is excited to join forces with NantOmics to help accelerate the field of precision medicine and precision health," said Mark Blumling, co-founder and CEO of Genos.

About NantOmics

NantOmics, a member of the NantWorks ecosystem of companies, delivers molecular diagnostic capabilities with the intent of providing actionable intelligence and molecularly driven decision support for cancer patients and their providers at the point of care. NantOmics is the first molecular diagnostics company to pioneer an integrated approach to unearthing the genomic and proteomic variances that initiate and drive cancer, by analyzing both normal and tumor cells from the same patient and following identified variances through from DNA to RNA to protein to drug. NantOmics has a highly scalable cloud-based infrastructure capable of storing and processing thousands of genomes a day, computing genomic variances in near real-time, and correlating proteomic pathway analysis with quantitative multi-plexed protein expression analysis from the same micro-dissected tumor sample used for genomic analysis. For more information please visit www.nantomics.com and follow Dr. Soon-Shiong on Twitter @DrPatSoonShiong.

About Genos

Genos is a platform for genomics research and discovery. The company's mission is to break down the barriers to accelerate disease research and medical cures. The Genos community democratizes access to comprehensive personal discovery through DNA, and empowers individuals to retain ownership of their genetic data and consent in the research process. Genos is backed by strategic investors with deep roots in health care and technology, and the company's advisors include luminaries in genetics, economics, and consumer technology.

Contact:
Mark Blumling
415-300-4477
mark@genosresearch.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nantomics-acquires-genos-to-bolster-its-precision-medicine-platform-300439634.html


'/>"/>
SOURCE Genos
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Spiral Therapeutics Acquires an Exclusive Option to Develop Two Neuroprotective Agents for the Treatment of Inner Ear Disorders
2. Digital Pharmacist Acquires PocketRx App
3. Alliar acquires Multiscan Imagem e Diagnostico
4. Serve You Acquires New England Mail Order Pharmacy
5. Atlantic Street Capital Portfolio Company Lombart Acquires INNOVA
6. LABORIE Acquires Andromeda
7. DXE Medical Acquires Cardio Partner Resources, Expands Cardiac Care Services Offering
8. ML Capital Group Acquires Stake in Colorado Highlife Tours Bolstering $1 Million 2017 Cannabis Tours Forecast
9. Auburn University acquires a Hyperbaric Veterinary Medicine Chamber, along with 3 other locations
10. Amygdala Neurosciences Acquires GS-6637 from Gilead Sciences
11. Hope Biosciences Acquires Worldwide Rights To Novel MERTK/AXL Inhibitor From NeoPharm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... -- The Rebound mobile app is poised to become a ... of prescription drug addiction. The app empowers users to develop ... down their dosage in a safe, controlled manner while maximizing ... first 100,000 people to sign up will enjoy 3 months ... ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading ... Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly ... CBD form that can be easily incorporated into liquid products, while reducing costs to ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
Breaking Medicine News(10 mins):